189 related articles for article (PubMed ID: 28319062)
1. CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic.
Marshall AD; Bailey CG; Champ K; Vellozzi M; O'Young P; Metierre C; Feng Y; Thoeng A; Richards AM; Schmitz U; Biro M; Jayasinghe R; Ding L; Anderson L; Mardis ER; Rasko JEJ
Oncogene; 2017 Jul; 36(29):4100-4110. PubMed ID: 28319062
[TBL] [Abstract][Full Text] [Related]
2. CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer.
Bailey CG; Metierre C; Feng Y; Baidya K; Filippova GN; Loukinov DI; Lobanenkov VV; Semaan C; Rasko JE
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513694
[TBL] [Abstract][Full Text] [Related]
3. Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial Cancer.
Walker CJ; Miranda MA; O'Hern MJ; McElroy JP; Coombes KR; Bundschuh R; Cohn DE; Mutch DG; Goodfellow PJ
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26330387
[TBL] [Abstract][Full Text] [Related]
4. High frequency strand slippage mutations in CTCF in MSI-positive endometrial cancers.
Zighelboim I; Mutch DG; Knapp A; Ding L; Xie M; Cohn DE; Goodfellow PJ
Hum Mutat; 2014 Jan; 35(1):63-5. PubMed ID: 24130125
[TBL] [Abstract][Full Text] [Related]
5. CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer.
Kemp CJ; Moore JM; Moser R; Bernard B; Teater M; Smith LE; Rabaia NA; Gurley KE; Guinney J; Busch SE; Shaknovich R; Lobanenkov VV; Liggitt D; Shmulevich I; Melnick A; Filippova GN
Cell Rep; 2014 May; 7(4):1020-9. PubMed ID: 24794443
[TBL] [Abstract][Full Text] [Related]
6. The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.
Tiffen JC; Bailey CG; Marshall AD; Metierre C; Feng Y; Wang Q; Watson SL; Holst J; Rasko JE
Int J Cancer; 2013 Oct; 133(7):1603-13. PubMed ID: 23553099
[TBL] [Abstract][Full Text] [Related]
7. De novo mutations in the genome organizer CTCF cause intellectual disability.
Gregor A; Oti M; Kouwenhoven EN; Hoyer J; Sticht H; Ekici AB; Kjaergaard S; Rauch A; Stunnenberg HG; Uebe S; Vasileiou G; Reis A; Zhou H; Zweier C
Am J Hum Genet; 2013 Jul; 93(1):124-31. PubMed ID: 23746550
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
[TBL] [Abstract][Full Text] [Related]
9. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
12. Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.
Rakha EA; Pinder SE; Paish CE; Ellis IO
Br J Cancer; 2004 Oct; 91(8):1591-6. PubMed ID: 15354217
[TBL] [Abstract][Full Text] [Related]
13. Structure-function relationships explain CTCF zinc finger mutation phenotypes in cancer.
Bailey CG; Gupta S; Metierre C; Amarasekera PMS; O'Young P; Kyaw W; Laletin T; Francis H; Semaan C; Sharifi Tabar M; Singh KP; Mullighan CG; Wolkenhauer O; Schmitz U; Rasko JEJ
Cell Mol Life Sci; 2021 Dec; 78(23):7519-7536. PubMed ID: 34657170
[TBL] [Abstract][Full Text] [Related]
14. Targeted mutation analysis of endometrial clear cell carcinoma.
Hoang LN; McConechy MK; Meng B; McIntyre JB; Ewanowich C; Gilks CB; Huntsman DG; Köbel M; Lee CH
Histopathology; 2015 Apr; 66(5):664-74. PubMed ID: 25308272
[TBL] [Abstract][Full Text] [Related]
15. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
McConechy MK; Anglesio MS; Kalloger SE; Yang W; Senz J; Chow C; Heravi-Moussavi A; Morin GB; Mes-Masson AM; ; Carey MS; McAlpine JN; Kwon JS; Prentice LM; Boyd N; Shah SP; Gilks CB; Huntsman DG
J Pathol; 2011 Apr; 223(5):567-73. PubMed ID: 21381030
[TBL] [Abstract][Full Text] [Related]
16. Molecular carcinogenesis of endometrial cancer.
Liu FS
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
[TBL] [Abstract][Full Text] [Related]
17. CTCF and BORIS in genome regulation and cancer.
Marshall AD; Bailey CG; Rasko JE
Curr Opin Genet Dev; 2014 Feb; 24():8-15. PubMed ID: 24657531
[TBL] [Abstract][Full Text] [Related]
18. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.
García-Sanz P; Triviño JC; Mota A; Pérez López M; Colás E; Rojo-Sebastián A; García Á; Gatius S; Ruiz M; Prat J; López-López R; Abal M; Gil-Moreno A; Reventós J; Matias-Guiu X; Moreno-Bueno G
Int J Cancer; 2017 Apr; 140(7):1551-1563. PubMed ID: 27997699
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
20. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
